Is my portfolio
One Report to Answer all your Questions!
Alivus Life Sciences Ltd.
BSE: 543322 | NSE: ALIVUS
Small Cap | Pharmaceuticals & Drugs
900.20
10.60 (1.19%) Glenmark Life Sciences informs about earnings call
Date: 22-10-2022Pursuant to the Regulation 30 and 46 read with Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Glenmark Life Sciences has informed that it uploaded audio recording of the Q2 FY2022-23 Earnings Call held on 21st October, 2022 on the website of the Company at: https://www.glenmarklifesciences.com/pdf/GLE9320221021143558.mp3
The above information is a part of company’s filings submitted to BSE.